Cargando…

Potent and Persistent Antibody Response in COVID-19 Recovered Patients

SARS-CoV-2 has caused a global pandemic with millions infected and numerous fatalities. Virus-specific antibodies can be detected in infected patients approximately two weeks after symptom onset. In this study, we set up ELISA technology coating with purified SARS-CoV-2 S and N proteins to study the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Xiaodong, Liu, Ling, Jiang, Wenguo, Zhang, He, Liu, Wenjun, Li, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193946/ https://www.ncbi.nlm.nih.gov/pubmed/34122416 http://dx.doi.org/10.3389/fimmu.2021.659041

Ejemplares similares

Persistence of the SARS-CoV-2 Antibody Response in Asymptomatic Patients in Correctional Facilities
por: Tian, Xiaodong, et al.
Publicado: (2021)

Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients
por: Cao, Zhiliang, et al.
Publicado: (2010)

Evaluation of Clinical and Immune Responses in Recovered Children with Mild COVID-19
por: Tian, Xiaodong, et al.
Publicado: (2022)

Longitudinal Dynamics of Cellular Responses in Recovered COVID-19 Patients
por: Cheng, Meng-Li, et al.
Publicado: (2022)

Longitudinal dynamics of antibody responses in recovered COVID-19 patients
por: Cheng, Meng-Li, et al.
Publicado: (2021)

Comparison of the mucosal and systemic antibody responses in Covid-19 recovered patients with one dose of mRNA vaccine and unexposed subjects with three doses of mRNA vaccines
por: Liu, Shaojun, et al.
Publicado: (2023)

Neutralizing Antibody Responses to SARS-CoV-2 in Recovered COVID-19 Patients Are Variable and Correlate With Disease Severity and Receptor-Binding Domain Recognition
por: Maciola, Agnieszka Katarzyna, et al.
Publicado: (2022)

An Fc-Competent Anti-Human TIGIT Blocking Antibody Ociperlimab (BGB-A1217) Elicits Strong Immune Responses and Potent Anti-Tumor Efficacy in Pre-Clinical Models
por: Chen, Xin, et al.
Publicado: (2022)

Monoclonal antibodies constructed from COVID-19 convalescent memory B cells exhibit potent binding activity to MERS-CoV spike S2 subunit and other human coronaviruses
por: Peng, Yuan, et al.
Publicado: (2022)

An Immunological Perspective: What Happened to Pregnant Women After Recovering From COVID-19?
por: Zhao, Sijia, et al.
Publicado: (2021)

SARS-CoV-2 tetrameric RBD protein blocks viral infection and induces potent neutralizing antibody response
por: Liu, Zheng, et al.
Publicado: (2022)

Identification of a HIV Gp41-Specific Human Monoclonal Antibody With Potent Antibody-Dependent Cellular Cytotoxicity
por: Yang, Zheng, et al.
Publicado: (2018)

Treatment With CD52 Antibody Protects Neurons in Experimental Autoimmune Encephalomyelitis Mice During the Recovering Phase
por: Hao, Wenlin, et al.
Publicado: (2021)

Long-Term Persistence of Robust Antibody and Cytotoxic T Cell Responses in Recovered Patients Infected with SARS Coronavirus
por: Li, Taisheng, et al.
Publicado: (2006)

Hypozincemia in COVID-19 Patients Correlates With Stronger Antibody Response
por: Xu, Wenye, et al.
Publicado: (2022)

The impact of supervised physical exercise on chemokines and cytokines in recovered COVID-19 patients
por: Filgueira, Tayrine Ordonio, et al.
Publicado: (2023)

Persistence of salivary antibody responses after COVID-19 vaccination is associated with oral microbiome variation in both healthy and people living with HIV
por: Ghorbani, Mahin, et al.
Publicado: (2023)

Development of a Potent and Protective Germline-Like Antibody Lineage Against Zika Virus in a Convalescent Human
por: Gao, Fei, et al.
Publicado: (2019)

Antibody Responses and the Effects of Clinical Drugs in COVID-19 Patients
por: Wei, Liwen, et al.
Publicado: (2021)

Case Report: ICIs-induced Guillain–Barré syndrome recovered from mycophenolate mofetil
por: Ding, Mengge, et al.
Publicado: (2023)

Antibody Responses in COVID-19: A Review
por: Chvatal-Medina, Mateo, et al.
Publicado: (2021)

Single-cell multiomics revealed the dynamics of antigen presentation, immune response and T cell activation in the COVID-19 positive and recovered individuals
por: Chattopadhyay, Partha, et al.
Publicado: (2022)

A Virus-Specific Immune Rheostat in the Immunome of Patients Recovering From Mild COVID-19
por: Yeo, Joo Guan, et al.
Publicado: (2021)

Persistence of Antibody Responses to the SARS-CoV-2 in Dialysis Patients and Renal Transplant Recipients Recovered from COVID-19
por: Cappuccilli, Maria, et al.
Publicado: (2021)

Double lock of a potent human therapeutic monoclonal antibody against SARS-CoV-2
por: Zhu, Ling, et al.
Publicado: (2020)

Antibodies in the breastmilk of COVID-19 recovered women
por: Szczygioł, Paulina, et al.
Publicado: (2022)

Persistent Symptoms in Patients Recovering From COVID-19 in Denmark
por: Leth, Steffen, et al.
Publicado: (2021)

The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factors
por: Xiang, Mengqi, et al.
Publicado: (2022)

Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative
por: Bonilla, Hector, et al.
Publicado: (2023)

A potent human neutralizing antibody Fc-dependently reduces established HBV infections
por: Li, Dan, et al.
Publicado: (2017)

A novel nanobody-based HER2-targeting antibody exhibits potent synergistic antitumor efficacy in trastuzumab-resistant cancer cells
por: Liu, Xinlin, et al.
Publicado: (2023)

Antibody Response to COVID-19 Booster Vaccination in Healthcare Workers
por: Pani, Arianna, et al.
Publicado: (2022)

Persistent white matter changes in recovered COVID-19 patients at the 1-year follow-up
por: Huang, Sihong, et al.
Publicado: (2021)

Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response
por: Pesce, Elisa, et al.
Publicado: (2022)

A tetravalent nanoparticle vaccine elicits a balanced and potent immune response against dengue viruses without inducing antibody-dependent enhancement
por: Chen, Qier, et al.
Publicado: (2023)

A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants
por: Shan, Sisi, et al.
Publicado: (2021)

Persistence of Anti-SARS-CoV-2 Antibodies in Long Term Care Residents Over Seven Months After Two COVID-19 Outbreaks
por: Tanunliong, Guadalein, et al.
Publicado: (2022)

Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes
por: Ceperuelo-Mallafré, Victòria, et al.
Publicado: (2022)

Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy
por: Chanzu, Nadia, et al.
Publicado: (2014)

Multi-Omics Integration Reveals Only Minor Long-Term Molecular and Functional Sequelae in Immune Cells of Individuals Recovered From COVID-19
por: Liu, Zhaoli, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_23bra0g8odqr9kns9gsh4hg0rb